UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
AbstractHigh-grade serous ovarian cancer is a deadly disease that can originate from the fallopian tube or the ovarian surface epithelium. The PAX (paired box) genes PAX2 and PAX8 are lineage-specific transcription factors required during development of the fallopian tube but not in the development of the ovary. PAX2 expression is lost early in serous cancer progression, while PAX8 is expressed ubiquitously. These proteins are implicated in migration, invasion, proliferation, cell survival, stem cell maintenance, and tumor growth. Hence, targeting PAX2 and PAX8 represents a promising drug strategy that could inhibit these pro-tumorigenic effects. In this review, we examine the implications of PAX2 and PAX8 expression in the cell of origin of serous cancer and their potential efficacy as drug targets by summarizing their role in the molecular pathogenesis of ovarian cancer. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Hardy, L.R.; Salvi, A.; Burdette, J.E. UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer. Cancers 2018, 10, 262.
Hardy LR, Salvi A, Burdette JE. UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer. Cancers. 2018; 10(8):262.Chicago/Turabian Style
Hardy, Laura R.; Salvi, Amrita; Burdette, Joanna E. 2018. "UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer." Cancers 10, no. 8: 262.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.